Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 14

    1.

    Analysis of signal transducer and activator of transcription 3 (Stat 3) pathway in multiple myeloma: Stat 3 activation and cyclin D1 dysregulation are mutually exclusive events.

    Quintanilla-Martinez L, Kremer M, Specht K, Calzada-Wack J, Nathrath M, Schaich R, Höfler H, Fend F.

    Am J Pathol. 2003 May;162(5):1449-61.PMID: 12707028 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Cytogenetics of multiple myeloma: interpretation of fluorescence in situ hybridization results.

    Harrison CJ, Mazzullo H, Cheung KL, Gerrard G, Jalali GR, Mehta A, Osier DG, Orchard KH.

    Br J Haematol. 2003 Mar;120(6):944-52.PMID: 12648063 [PubMed - indexed for MEDLINE]Related articles

    3.

    The biology and cytogenetics of multiple myeloma.

    Ho PJ, Campbell LJ, Gibson J, Brown R, Joshua D.

    Rev Clin Exp Hematol. 2002 Sep;6(3):276-300. Review.PMID: 12616699 [PubMed - indexed for MEDLINE]Related articles

    4.

    Cell cycle regulators in multiple myeloma: prognostic implications of p53 nuclear accumulation.

    Pruneri G, Carboni N, Baldini L, Intini D, Colombi M, Bertolini F, Valentini S, Maisonneuve P, Viale G, Neri A.

    Hum Pathol. 2003 Jan;34(1):41-7.PMID: 12605365 [PubMed - indexed for MEDLINE]Related articles

    5.

    MYEOV: a candidate gene for DNA amplification events occurring centromeric to CCND1 in breast cancer.

    Janssen JW, Cuny M, Orsetti B, Rodriguez C, Vallés H, Bartram CR, Schuuring E, Theillet C.

    Int J Cancer. 2002 Dec 20;102(6):608-14.PMID: 12448002 [PubMed - indexed for MEDLINE]Related articles

    7.

    Comparison of gene expression profiling between malignant and normal plasma cells with oligonucleotide arrays.

    De Vos J, Thykjaer T, Tarte K, Ensslen M, Raynaud P, Requirand G, Pellet F, Pantesco V, Rème T, Jourdan M, Rossi JF, Ørntoft T, Klein B.

    Oncogene. 2002 Oct 3;21(44):6848-57.PMID: 12360412 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Role of the phosphatidylinositol 3-kinase/Akt and mTOR/P70S6-kinase pathways in the proliferation and apoptosis in multiple myeloma.

    Pene F, Claessens YE, Muller O, Viguié F, Mayeux P, Dreyfus F, Lacombe C, Bouscary D.

    Oncogene. 2002 Sep 26;21(43):6587-97.PMID: 12242656 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Identification of cyclin D1 mRNA overexpression in B-cell neoplasias by real-time reverse transcription-PCR of microdissected paraffin sections.

    Specht K, Kremer M, Müller U, Dirnhofer S, Rosemann M, Höfler H, Quintanilla-Martinez L, Fend F.

    Clin Cancer Res. 2002 Sep;8(9):2902-11.PMID: 12231535 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Enhanced sensitivity of multiple myeloma cells containing PTEN mutations to CCI-779.

    Shi Y, Gera J, Hu L, Hsu JH, Bookstein R, Li W, Lichtenstein A.

    Cancer Res. 2002 Sep 1;62(17):5027-34.PMID: 12208757 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    MYEOV, a gene at 11q13, is coamplified with CCND1, but epigenetically inactivated in a subset of esophageal squamous cell carcinomas.

    Janssen JW, Imoto I, Inoue J, Shimada Y, Ueda M, Imamura M, Bartram CR, Inazawa J.

    J Hum Genet. 2002;47(9):460-4.PMID: 12202983 [PubMed - indexed for MEDLINE]Related articles

    12.

    Alterations of the cyclin D1/pRb/p16(INK4A) pathway in multiple myeloma.

    Krämer A, Schultheis B, Bergmann J, Willer A, Hegenbart U, Ho AD, Goldschmidt H, Hehlmann R.

    Leukemia. 2002 Sep;16(9):1844-51.PMID: 12200702 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Genomic abnormalities in monoclonal gammopathy of undetermined significance.

    Fonseca R, Bailey RJ, Ahmann GJ, Rajkumar SV, Hoyer JD, Lust JA, Kyle RA, Gertz MA, Greipp PR, Dewald GW.

    Blood. 2002 Aug 15;100(4):1417-24.PMID: 12149226 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Myeloma and the t(11;14)(q13;q32); evidence for a biologically defined unique subset of patients.

    Fonseca R, Blood EA, Oken MM, Kyle RA, Dewald GW, Bailey RJ, Van Wier SA, Henderson KJ, Hoyer JD, Harrington D, Kay NE, Van Ness B, Greipp PR.

    Blood. 2002 May 15;99(10):3735-41.PMID: 11986230 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Find related data

    Search details

    » See more...